Epibatidine
ADVERTISEMENT
- Molecular formula
- C11H13ClN2
- CAS Number
- 140186-81-0
- IUPAC Name
- 2-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane
- Molecular Weight
- 208.68g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.4450g/cm3
- Appearance
- is usually described as white or off-white crystals or powder.
- Synonyms
- Epibatidine
Identification
Interesting facts
Interesting Facts about 2-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane
The compound 2-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane, commonly referred to in the field of medicinal chemistry, is a fascinating molecule with a variety of applications. Below are some noteworthy facts:
- Structural Uniqueness: This compound features a bicyclic structure, which imparts unique chemical properties and stability, making it attractive for drug design.
- Pharmacological Potential: It belongs to a class of molecules that are investigated for their potential therapeutic effects, particularly in the realm of neuropharmacology.
- Chlorine Influence: The presence of the chlorine atom greatly affects the reactivity and interactions of the molecule, often enhancing its biological activity.
- Pyridine Ring: The incorporation of a pyridine ring not only adds to structural complexity but also contributes to its electron-withdrawing properties, altering the electron density within the molecule.
- Synthetic Routes: Chemists are continually exploring various synthetic pathways to create this and related compounds, which often involves intricate organic reactions.
- Research Insights: Recent studies suggest that derivatives of this compound might offer new insights into the treatment of neurological disorders, showcasing its importance in ongoing pharmaceutical research.
As emphasized by renowned chemists, "The key to innovation lies in the exploration of the molecular world." Compounds like 2-(6-chloro-3-pyridyl)-7-azabicyclo[2.2.1]heptane exemplify this exploration and reveal just how interconnected chemistry is with advancements in medicine.